Advanced search
Publication Cover
Journal of Inflammation Research Volume 15, 2022 - Issue
Submit an article Journal homepage
72
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Preoperative White Blood Cell-Related Indicators Can Predict the Prognosis of Patients with Transurethral Resection of Bladder Cancer

Mingde Gao1 Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1735-787XView further author information
ORCID Icon,
Qiuxing Yang2 Department of Central Laboratory, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, People’s Republic of ChinaView further author information
,
Haifei Xu1 Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, People’s Republic of ChinaView further author information
,
Zhigang Chen1 Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, People’s Republic of ChinaView further author information
,
Xiaolin Wang1 Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0001-9226-7201View further author information
ORCID Icon &
Haifeng Guo1 Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, 226361, People’s Republic of ChinaView further author information
Pages 4139-4147 | Published online: 21 Jul 2022

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Cumberbatch M, Jubber I, Black PC, et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–795. doi:10.1016/j.eururo.2018.09.001
  • Lenis AT, Lec PM, Chamie K. Bladder cancer. JAMA. 2020;324(19):2006. doi:10.1001/jama.2020.17601
  • Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21(2):104–121. doi:10.1038/s41568-020-00313-1
  • Westhoff E, Witjes JA, Fleshner NE, et al. Body mass index, diet-related factors, and bladder cancer prognosis: a systematic review and meta-analysis. Bladder Cancer. 2018;4(1):91–112. doi:10.3233/BLC-170147
  • Hou L, Hong X, Dai M, et al. Association of smoking status with prognosis in bladder cancer: a meta-analysis. Oncotarget. 2017;8(1):1278–1289. doi:10.18632/oncotarget.13606
  • Liu X, Zhao W, Wang X, Zhu Y, Zhou Z, Shi B. Expression of mir-143 in serum of bladder cancer patients and its correlation with clinical features and prognosis. J BUON. 2019;24(2):791–796.
  • Zhu J, Zheng G, Xu H, Jin X, Tang T, Wang X. Expression and prognostic significance of pyruvate dehydrogenase kinase 1 in bladder urothelial carcinoma. Virchows Arch. 2020;477(5):637–649. doi:10.1007/s00428-020-02782-z
  • Zhang Q, Lai Q, Wang S, Meng Q, Mo Z. Clinical value of postoperative neutrophil-to-lymphocyte ratio change as a detection marker of bladder cancer recurrence. Cancer Manag Res. 2021;13:849–860. doi:10.2147/CMAR.S289986
  • Wang X, Ni X, Tang G. Prognostic role of platelet-to-lymphocyte ratio in patients with bladder cancer: a meta-analysis. Front Oncol. 2019;9:757. doi:10.3389/fonc.2019.00757
  • Wang R, Yan Y, Liu S, Yao X. Comparison of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios in bladder cancer patients undergoing radical cystectomy. Biomed Res Int. 2019;2019:3628384. doi:10.1155/2019/3628384
  • Zheng HL, Lu J, Xie JW, et al. Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients. BMC Cancer. 2019;19(1):1127. doi:10.1186/s12885-019-6213-0
  • Ku JH, Kang M, Kim HS, Jeong CW, Kwak C, Kim HH. The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy. Br J Cancer. 2015;112(3):461–467. doi:10.1038/bjc.2014.631
  • Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306. doi:10.1038/nrc3245
  • Lucca I, Jichlinski P, Shariat SF, et al. The neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy: validation and meta-analysis. Eur Urol Focus. 2016;2(1):79–85. doi:10.1016/j.euf.2015.03.001
  • Rajwa P, Życzkowski M, Paradysz A, Bujak K, Bryniarski P. Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy. Eur Rev Med Pharmacol Sci. 2018;22(10):3027–3037. doi:10.26355/eurrev_201805_15060
  • Yıldız HA, Değer MD, Aslan G. Prognostic value of preoperative inflammation markers in non-muscle invasive bladder cancer. Int J Clin Pract. 2021;75(6):e14118. doi:10.1111/ijcp.14118
  • Ojerholm E, Smith A, Hwang WT, et al. Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: assessing prognostic and predictive value in SWOG 8710. Cancer. 2017;123(5):794–801. doi:10.1002/cncr.30422

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.